Doban Bio announced that it signed a ‘technology implementation contract for anticancer immune cell (NK cell) treatment’ with the Southeast Nuclear Medicine Institute.
With this contract, Doban Bio announced that it has secured the original technology to produce NK immune cell treatment using natural killer cells (NK cells) by utilizing the ‘High-efficiency mass proliferation method of natural killer cells isolated from whole blood’ (Patent 10-2256272) of the Southeast Nuclear Medicine Institute. ‘Natural killer cells’ (NK cells) are important immune cells that serve as the initial line of defense in the human immune system.
Recently, the number and function of NK cells have been reduced in cancer patients, and activating them has emerged as an important cancer treatment strategy. However, NK cells are difficult to mass proliferate in vitro, so their existing clinical application has been limited.
According to Doban Bio, this technology developed by the Southeast Nuclear Medicine Institute can overcome these limitations and mass-produce high-purity NK cells using radiation technology. This can be applied to autologous and allogeneic treatments, and is said to be a platform technology that can be expanded to mass-cultivate CAR-NK cells, a cell gene therapy.
Meanwhile, the Southeast Nuclear Medicine Institute is a specialized science and technology hospital under the Ministry of Science and ICT and is a leading institution in the development of radiology technology. Doban Bio is a cooperative institution of Doban Oriental Hospital, which operates the Cancer Immunity Center and the Regenerative Medicine Center, and specializes in immune cell and stem cell research and conducts personalized immune care business.
Doban Bio CEO Jeong Hyeon-jae said, “These NK cells can be applied to various types of cancer, and we expect their effectiveness to increase when used in combination with existing anticancer treatments.” He added, “In the future, based on the treatment know-how acquired from the Cancer Immunity Center, which encompasses Oriental and Western medicine and regenerative medicine at Doban Oriental Hospital, we will continue to research regenerative medicine anticancer treatments to enhance immunity and lead the growth of the bio health field.”
Reporter Yong-Seok Choi, Donga.com [email protected]
-
- great
- 0dog
-
- I’m sad
- 0dog
-
- I’m angry
- 0dog
-
- I recommend it
- dog
Hot news right now
2024-09-02 16:16:30